Donald Marvin - 16 Mar 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Executive VP, CFO & COO
Signature
/s/ Matthew Rudolph, Attorney-in-Fact for Donald Marvin.
Issuer symbol
CMMB
Transactions as of
16 Mar 2022
Transactions value $
$1,638
Form type
4
Filing time
21 Jun 2022, 06:01:38 UTC
Previous filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMMB American Depositary Shares Purchase $825 +250 +16.7% $3.30 1,750 16 Mar 2022 Direct F1
transaction CMMB American Depositary Shares Purchase $812 +250 +14.3% $3.25 2,000 16 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +196,875 $0.000000 196,875 08 Nov 2021 American Depositary Shares 196,875 $9.77 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3 The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.